Newsroom | 30637 results

CHICAGO & NEW YORK & SAN DIEGO--(BUSINESS WIRE)--24/364 Rare Disease Film Festival to Debut in San Diego, Inviting Audiences to See Life Beyond the Disease...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics Presents Exploratory Biomarker Data at AAIC 2026 Supporting Coordinated Modulation of Lipid Transport and Myelination Pathways...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options, announced today the pricing of an underwritten registered direct offering of 3,776,436 shares of its common stock at a price of $26.48 per share. All of the shares are being offered by Alto. The gross proceeds from the offering are expected...

SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery announces collaboration with Novartis to advance AI-driven antibody discovery...

PRINCETON, N.J.--(BUSINESS WIRE)--U.S. FDA Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma...

SEATTLE--(BUSINESS WIRE)--Concord Releases Report on AI-Driven Interoperability and Operational Efficiency in American Hospital Association Market Scan Trailblazer report....

DOVER, Del.--(BUSINESS WIRE)--Precisio announced the continuation of its expanded access program, with dosing of a staph lysin called ClyO (LYSG101) to a patient with chronic prosthetic joint infection. Under an FDA-approved expanded-access IND, administration of ClyO was initiated on June 1. The treatment follows a 4 month protocol with a minimum 6 month follow-up. Outcomes to be tracked include safety, improvements of clinical signs and symptoms, and either durable eradication or sustained sup...

ATLANTA--(BUSINESS WIRE)--Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Technologies and Paragon Energy Solutions businesses supported multiple advanced reactor designs that have achieved criticality milestones in the U.S. Department of Energy (DOE) Reactor Pilot Program, established under Executive Order 14301. In May 2025, the Administration issued executive orders to strengthen and accelerate the U.S. nuclear industry. Executive Order 143...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that, on July 5, 2026, the Compensation Committee of Precision’s Board of Directors approved the grant of inducement awards to new employees under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan (“Inducement Award Plan...

سان ماتيو، كاليفورنيا--(BUSINESS WIRE)--أسهمت أول تجربة سريرية عشوائية محكمة (RCT) من نوعها، نُشرت اليوم في مجلة Schizophrenia Bulletin، وأجراها باحثون من جامعة كاليفورنيا في سان فرانسيسكو (UCSF) بتمويل جزئي من المعهد الوطني للصحة النفسية (NIMH)، في إثراء قاعدة الأدلة العلمية المتزايدة التي تشير إلى الفوائد المحتملة للنظام الغذائي الكيتوني في علاج الاضطرابات الذهانية. وأظهرت الدراسة، التي ضمّت مشاركين مصابين باضطرابات طيف الفصام أو اضطراب ثنائي القطب من النوع الأول، أن اتباع النظام الغذائي الكيت...